Symbol
QNRX on Nasdaq
Investment type
Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Latest Disclosed Shares Owned
2,785,370 shares
Security Ownership %
9.5%
Shares, Excluding Options vs Price
Value, Excluding Options

Woodline Partners LP ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

17 Feb 2026 - Woodline Partners LP has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,785,370 shares of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 9.5% ownership of the company. This is the first filing by Woodline Partners LP disclosing ownership of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.